Speaker for Nanotechnology Conferences  2020
Dr. Stefaan W. Van Gool
Immuno-Oncological Centre Cologne (IOZK), Germany

Dr. Stefaan Van Gool, MD, PhD started his career at the KU Leuven as Professor for Pediatric neuro-oncology in 1996. He pioneered dendritic cell vaccination for children and adults with glioblastoma multiforme, and treated the first patient in Europe in 2001. He worked out the complete translational research path from basic science till implementation in patient treatment. Since 2018, he is the director of the Praxis für Immunonkologie & Translationale Medizin, where IO-Vac® dendritic cell vaccines became an approved medicinal product for use in human. Main focus is the integration of individualized multimodal immunotherapy as part of multiphase combined treatment strategies against cancer.